Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Intelligent Bio Solutions ( (INBS) ).
On September 20, 2025, Intelligent Bio Solutions Inc. announced the extension of the termination date for its Series H-1 Common Stock Purchase Warrants from September 27, 2025, to March 27, 2026. This decision, which does not alter the exercise prices or other terms, was made with the consent of all six warrant holders, affecting 1,034,213 shares of common stock, and was executed without any additional consideration or agreements.
The most recent analyst rating on (INBS) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Intelligent Bio Solutions stock, see the INBS Stock Forecast page.
Spark’s Take on INBS Stock
According to Spark, TipRanks’ AI Analyst, INBS is a Neutral.
The overall stock score is primarily impacted by the company’s weak financial performance, characterized by consistent losses and negative cash flows. Technical analysis suggests a bearish trend, with the stock trading below key moving averages. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, further weighing down the score.
To see Spark’s full report on INBS stock, click here.
More about Intelligent Bio Solutions
Average Trading Volume: 208,105
Technical Sentiment Signal: Sell
Current Market Cap: $12.35M
For an in-depth examination of INBS stock, go to TipRanks’ Overview page.